Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Majdi Osman

Achievements

—Dr. Majdi Osman is an internationally recognized physician-scientist and global health leader specializing in microbiome therapeutics, fecal microbiota transplantation (FMT), and translational gut health research. He holds a Doctor of Medicine (MD) and a Master of Public Health (MPH), with academic affiliations including the University of Cambridge and the Wellcome Sanger Institute in the United Kingdom. Dr. Osman served as the Chief Medical Officer and Clinical Director at OpenBiome—the world's first public stool bank—where he spearheaded donor screening frameworks and clinical oversight for over 70,000 microbiota transfer treatments distributed for recurrent Clostridioides difficile infections and experimental clinical trials globally. His translational research focuses on harnessing microbiota transfer therapies and microbiome-based biotherapeutics to address critical public health challenges, including pediatric malnutrition, severe food allergies, diarrheal disease, and inflammatory disorders. In addition to his clinical research, Dr. Osman advises international biomedical companies, research consortia, and government agencies on translating laboratory microbiome discoveries into scalable therapeutics. He serves on the Microbiome Committee of the US Presidential Advisory Council and is a Trustee of the Africa Research Excellence Fund. He has authored landmark scientific studies in leading peer-reviewed journals, including Nature, Gastroenterology, The New England Journal of Medicine, and Science Translational Medicine. As a featured faculty speaker at Sidra Medicine’s MENA Microbiome Conference 2026, Dr. Osman brings scientific and clinical perspectives. His presentations center on establishing clinical-grade microbiota therapies, designing microbiota-based clinical trials, and leveraging precision microbiome insights to address systemic and regional health challenges.
—Former Chief Medical Officer and Co-Founder at OpenBiome, overseeing clinical safety and delivery of over 70,000 FMT therapies globally.
—Pioneer in establishing donor screening protocols and clinical trial frameworks for microbiota transfer therapy (MTT) across diverse patient cohorts.

Dr. Majdi Osman

Physician-Scientist, Clinical Research Fellow & Microbiome Therapeutics Advisor

University of Cambridge & Wellcome Sanger Institute, United Kingdom

About

Dr. Majdi Osman is an internationally recognized physician-scientist and global health leader specializing in microbiome therapeutics, fecal microbiota transplantation (FMT), and translational gut health research. He holds a Doctor of Medicine (MD) and a Master of Public Health (MPH), with academic affiliations including the University of Cambridge and the Wellcome Sanger Institute in the United Kingdom. Dr. Osman served as the Chief Medical Officer and Clinical Director at OpenBiome—the world's first public stool bank—where he spearheaded donor screening frameworks and clinical oversight for over 70,000 microbiota transfer treatments distributed for recurrent Clostridioides difficile infections and experimental clinical trials globally. His translational research focuses on harnessing microbiota transfer therapies and microbiome-based biotherapeutics to address critical public health challenges, including pediatric malnutrition, severe food allergies, diarrheal disease, and inflammatory disorders. In addition to his clinical research, Dr. Osman advises international biomedical companies, research consortia, and government agencies on translating laboratory microbiome discoveries into scalable therapeutics. He serves on the Microbiome Committee of the US Presidential Advisory Council and is a Trustee of the Africa Research Excellence Fund. He has authored landmark scientific studies in leading peer-reviewed journals, including Nature, Gastroenterology, The New England Journal of Medicine, and Science Translational Medicine. As a featured faculty speaker at Sidra Medicine’s MENA Microbiome Conference 2026, Dr. Osman brings scientific and clinical perspectives. His presentations center on establishing clinical-grade microbiota therapies, designing microbiota-based clinical trials, and leveraging precision microbiome insights to address systemic and regional health challenges.

Events & Activities

MENA Microbiome Conference 2026: From Biomarkers Discovery to Microbiota-based Therapeutics
Oct 17, 2026
In-Person
Oct 17, 2026
In-Person

MENA Microbiome Conference 2026: From Biomarkers Discovery to Microbiota-based Therapeutics

Free

The MENA Microbiome Conference 2026: From Biomarker Discovery to Microbiota-Based Therapeutics explores emerging research and clinical advances in the human microbiome and its role in health and disease. The conference brings together researchers and healthcare professionals to examine the development of microbiome-based biomarkers, diagnostics, and therapeutic approaches.

Sidra Medicine

  • 2 Days
  • Andaz Hotel – Sahara Ballroom
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
Dr. Majdi Osman — Physician-Scientist, Clinical Research Fellow… | MedArena